Somite AI is a Boston-based biotechnology startup founded in 2023, aiming to revolutionize regenerative medicine by applying artificial intelligence to stem cell biology. The company is developing DeltaStem, an AI foundation model designed to generate any human cell type on demand, transforming cell therapy development from a trial-and-error process into a computationally driven discipline.

At the core of Somite's approach is its proprietary capsule technology, which enables the generation of cell state transition data at a scale and efficiency surpassing current methods by a factor of 1,000. This data feeds into DeltaStem, accelerating the discovery and optimization of cell differentiation protocols. The goal is to produce pure, functional, and scalable cell types more rapidly and reliably than traditional methods.